ClinicalTrialsFinder

RET Gene Mutation Clinical Trials in Changsha, Hunan

1 recruitingChangsha, Hunan, China

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

Non-small Cell Lung CancerMET AmplificationEGF-R Positive Non-Small Cell Lung Cancer+1 more
Hunan Province Tumor Hospital120 enrolled1 locationNCT06109558